Professional Documents
Culture Documents
TM
Description:
is a transdermal therapeutic patch containing the active pharmaceutical ingredient Fentanyl.
It is about 100 times more potent than Morphine, and a strong pain medication for moderate to severe chronic pain.
delivers Fentanyl into the body through the skin at the designated rate, reaching efficient blood level within
a few hours after the application. The pain is relieved for up to 72 hours; therefore, it becomes the first drug of choice
in cancer pain management therapy.
Backing Cloth
Release
Liner
Adhesive (Drug)
1.25 mg
5 cm2
12.5 micrograms/hour
25 mcg/hr
2.5 mg
10 cm2
25 micrograms/hour
50 mcg/hr
5.0 mg
20 cm
50 micrograms/hour
75 mcg/hr
7.5 mg
30 cm
75 micrograms/hour
100 mcg/hr
10.0 mg
40 cm
100 micrograms/hour
12.5 mcg/hr
Indication
(Fentanyl transdermal patch) is indicated in the management of chronic intractable pain that requires
continuous opioid analgesia.
Initial Dose
The appropriate initiating dose of
should be based on the patient's current opioid use. It is recommended
that
should be used in patients who have demonstrated opioid tolerance. Other factors to be considered
are the current general condition and medical status of the patient, including body size, age and extent of debilitation
as well as degree of opioid tolerance.
Precautions
Application site is preferably void of hair, and must be clean and dry. Wash the site before applying patch
Do not apply
Do not apply
where cosmetics such as cream, lotion, gel etc., are already applied
Do not apply
must be applied only one time. It should not be removed/re-applied; adhesive stickiness is
reduced when the
patch is re-applied
After removal of a previous
should not be applied when the patient has a fever, because the high body temperature will
cause an increased rate of Fentanyl delivery
w w.
sparsha.com
Phone (040) 2335-2581 / 83 Fax: w
(040)
2335-2580
email : info@sparsha.com / marketing@sparsha.com
www.sparsha.com